Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2015, Article ID 164840, 7 pages
http://dx.doi.org/10.1155/2015/164840
Research Article

Epstein-Barr Virus Association with Peptic Ulcer Disease

1Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias (UIMEIP), Hospital de Pediatría, CMN Siglo-XXI, Instituto Mexicano del Seguro Social (IMSS), Avenida Cuauhtémoc 330, Colonia Doctores, Delegación Cuauhtémoc, 06720 Ciudad de México, DF, Mexico
2Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Avenida Universidad 655, Colonia Santa María Ahuacatitlán, 62100 Cuernavaca, MOR, Mexico
3Unidad de Investigación en Virología y Cáncer, Hospital Infantil de México Federico Gómez, Dr. Márquez 162, Colonia Doctores, Delegación Cuauhtémoc, 06720 Ciudad de México, DF, Mexico

Received 30 April 2015; Accepted 15 June 2015

Academic Editor: Francisco Aguayo Gonzalez

Copyright © 2015 María G. Cárdenas-Mondragón et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Y. Lee, C. B. Wang, T. T. Chen et al., “A tool to predict risk for gastric cancer in patients with peptic ulcer disease on the basis of a nationwide cohort,” Clinical Gastroenterology and Hepatology, vol. 13, no. 2, pp. 287.e1–293.e1, 2015. View at Publisher · View at Google Scholar
  2. L.-E. Hansson, “Risk of stomach cancer in patients with peptic ulcer disease,” World Journal of Surgery, vol. 24, no. 3, pp. 315–320, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Thun, J. O. DeLancey, M. M. Center, A. Jemal, and E. M. Ward, “The global burden of cancer: priorities for prevention,” Carcinogenesis, vol. 31, no. 1, pp. 100–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Ubukata, H. Nagata, T. Tabuchi, S. Konishi, T. Kasuga, and T. Tabuchi, “Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer,” Gastric Cancer, vol. 14, no. 1, pp. 4–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Jyotheeswaran, A. N. Shah, H. O. Jin, G. D. Potter, F. V. Ona, and W. Y. Chey, “Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?” The American Journal of Gastroenterology, vol. 93, no. 4, pp. 574–578, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. A. A. Ciociola, D. J. McSorley, K. Turner, D. Sykes, and J. B. D. Palmer, “Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated,” The American Journal of Gastroenterology, vol. 94, no. 7, pp. 1834–1840, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Iijima, T. Kanno, T. Koike, and T. Shimosegawa, “Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia,” World Journal of Gastroenterology, vol. 20, no. 3, pp. 706–713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Laine, R. J. Hopkins, and L. S. Girardi, “Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials,” The American Journal of Gastroenterology, vol. 93, no. 9, pp. 1409–1415, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Murphy, R. Pfeiffer, M. C. Camargo, and C. S. Rabkin, “Meta-analysis shows that prevalence of epstein-barr virus-positive gastric cancer differs based on sex and anatomic location,” Gastroenterology, vol. 137, no. 3, pp. 824–833, 2009. View at Publisher · View at Google Scholar
  10. M. C. Camargo, G. Murphy, C. Koriyama et al., “Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis,” British Journal of Cancer, vol. 105, no. 1, pp. 38–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. L. E. Martínez-López, J. Torres, M. Camorlinga-Ponce, A. Mantilla, Y. A. Leal, and E. M. Fuentes-Pananá, “Evidence of Epstein-Barr virus association with gastric cancer and non-atrophic gastritis,” Viruses, vol. 6, no. 1, pp. 301–318, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Shibata and L. M. Weiss, “Epstein-Barr virus-associated gastric adenocarcinoma,” American Journal of Pathology, vol. 140, no. 4, pp. 769–774, 1992. View at Google Scholar · View at Scopus
  13. R. Durmaz, A. Aydin, M. Köroglu, B. Durmaz, and H. Çiralik, “Investigation of the relationship between Epstein-Barr virus and ordinary gastric carcinoma using the nested polymerase chain reaction,” Acta Virologica, vol. 42, no. 6, pp. 359–363, 1998. View at Google Scholar · View at Scopus
  14. A. Hirano, H. Yanai, N. Shimizu et al., “Evaluation of epstein-barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay,” International Journal of Gastrointestinal Cancer, vol. 34, no. 2-3, pp. 87–94, 2004. View at Google Scholar · View at Scopus
  15. Y. Kaizaki, S. Sakurai, J.-M. Chong, and M. Fukayama, “Atrophic gastritis, Epstein-Barr virus infection, and Epstein-Barr virus-associated gastric carcinoma,” Gastric Cancer, vol. 2, no. 2, pp. 101–108, 1999. View at Publisher · View at Google Scholar
  16. H. Yanai, K. Takada, N. Shimizu, Y. Mizugaki, M. Tada, and K. Okita, “Epstein-Barr virus infection in non-carcinomatous gastric epithelium,” The Journal of Pathology, vol. 183, no. 3, pp. 293–298, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Saxena, K. Nath Prasad, U. Chand Ghoshal, N. Krishnani, M. Roshan Bhagat, and N. Husain, “Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease,” Scandinavian Journal of Gastroenterology, vol. 43, no. 6, pp. 669–674, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. K. Shukla, K. N. Prasad, A. Tripathi et al., “Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases,” Brazilian Journal of Infectious Diseases, vol. 15, no. 6, pp. 583–590, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Ohnishi, H. Yuasa, S. Tanaka et al., “Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 3, pp. 1003–1008, 2008. View at Publisher · View at Google Scholar
  20. L.-J. van Doorn, P. M. Schneeberger, N. Nouhan, A. P. Plaisier, W. G. V. Quint, and W. A. De Boer, “Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment,” Gut, vol. 46, no. 3, pp. 321–326, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. A. F. Novaes De Magalhães, A. Carvalhaes, J. Natan-Eisig, J. G. Paraíso-Ferraz, M. Trevisan, and S. Zaterka, “CagA status and Helicobacter pylori eradication among dyspeptic patients,” Gastroenterologia y Hepatologia, vol. 28, no. 8, pp. 441–444, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. G. Cardenas-Mondragon, J. Torres, L. Flores-Luna et al., “Case-control study of Epstein-Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease,” British Journal of Cancer, vol. 112, pp. 1866–1873, 2015. View at Publisher · View at Google Scholar
  23. M. G. Cárdenas-Mondragón, R. Carreón-Talavera, M. Camorlinga-Ponce, A. Gomez-Delgado, J. Torres, and E. M. Fuentes-Pananá, “Epstein Barr virus and Helicobacter pylori co-infection are positively associated with severe gastritis in pediatric patients,” PLoS ONE, vol. 8, no. 4, Article ID e62850, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. F. Dixon, R. M. Genta, J. H. Yardley, and P. Correa, “Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994,” The American Journal of Surgical Pathology, vol. 20, no. 10, pp. 1161–1181, 1996. View at Google Scholar
  25. E. Kasamatsu, L. E. Bravo, J. C. Bravo et al., “Reproducibility of histopathologic diagnosis of precursor lesions of gastric carcinoma in three Latin American countries,” Salud Pública de México, vol. 52, no. 5, pp. 386–390, 2010. View at Google Scholar
  26. M. Camorlinga-Ponce, J. Torres, G. Perez-Perez et al., “Validation of a serologic test for the diagnosis of Helicobacter pylori infection and the immune response to urease and CagA in children,” The American Journal of Gastroenterology, vol. 93, no. 8, pp. 1264–1270, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Camorlinga-Ponce, L. Flores-Luna, E. Lazcano-Ponce et al., “Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 9, pp. 2498–2504, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Shousha and Y. A. Luqmani, “Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa,” Journal of Clinical Pathology, vol. 47, no. 8, pp. 695–698, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. A. J. Schetter, W.-C. You, E. T. Lennette, M. T. Gail, and C. S. Rabkin, “Association of Epstein-Barr virus antibody levels with precancerous gastric lesions in a high-risk cohort,” Cancer Science, vol. 99, no. 2, pp. 350–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. S.-M. Cao, Z. Liu, W.-H. Jia et al., “Fluctuations of Epstein-Barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up,” PLoS ONE, vol. 6, no. 4, Article ID e19100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Y.-C. Chien, J.-Y. Chen, M.-Y. Liu et al., “Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men,” The New England Journal of Medicine, vol. 345, no. 26, pp. 1877–1882, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. M. F. Ji, D. K. Wang, Y. L. Yu et al., “Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma,” British Journal of Cancer, vol. 96, no. 4, pp. 623–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. K. J. Yu, W.-L. Hsu, R. M. Pfeiffer et al., “Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families,” Clinical Cancer Research, vol. 17, no. 7, pp. 1906–1914, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. E. Coghill and A. Hildesheim, “Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature,” American Journal of Epidemiology, vol. 180, no. 7, pp. 687–695, 2014. View at Publisher · View at Google Scholar
  35. Z. Liu, M.-F. Ji, Q.-H. Huang et al., “Two epstein-barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China,” American Journal of Epidemiology, vol. 177, no. 3, pp. 242–250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. M. B. Edwards and M. Woodroof, “EB virus specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages,” Journal of Clinical Pathology, vol. 32, no. 10, pp. 1036–1040, 1979. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Mueller, A. Mohar, A. Evans, and N. L. Harris, “Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma,” International Journal of Cancer, vol. 49, no. 3, pp. 387–393, 1991. View at Publisher · View at Google Scholar · View at Scopus